Biora Therapeutics, Inc. Convertible Notes Payable, Noncurrent
Biora Therapeutics, Inc. had Convertible Notes Payable, Noncurrent of $0 as of 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt, Excluding Current Maturities
us-gaap:ConvertibleLongTermNotesPayable · last filed 2024-11-14
- 2024-09-30: Convertible Notes Payable, Noncurrent $0.00.
- 2024-06-30: Convertible Notes Payable, Noncurrent $4.51M.
- 2024-03-31: Convertible Notes Payable, Noncurrent $4.50M.
- 2023-12-31: Convertible Notes Payable, Noncurrent $9.97M.
| Period end | Convertible Notes Payable, Noncurrent |
|---|---|
| 2024-09-30 | $0.00 10-Q · filed 2024-11-14 |
| 2024-06-30 | $4.51M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $4.50M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $9.97M 10-Q · filed 2024-11-14 |
| 2023-09-30 | $80.38M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $128.57M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $128.19M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $127.81M 10-K · filed 2024-04-01 |
| 2022-09-30 | $127.44M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $127.09M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $126.74M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $126.39M 10-K · filed 2023-03-30 |
| 2021-09-30 | $156.04M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $157.53M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $159.20M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $158.89M 10-K · filed 2022-03-28 |